MedTrace Logo

Probiotics Use in the Chronic Peritoneal Dialysis Patients

NCT01076426 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2010-02-26

No results posted yet for this study

Summary

The purpose of this study is to determine whether probiotics can improve the nutrition status and prevent peritonitis in the chronic peritoneal dialysis patients.

Conditions

  • Peritonitis
  • Malnutrition

Interventions

DRUG

Pro-biotics

Pro-biotics and placebo one pack per day is given to the two group. And then evaluate the peritonitis rate and nutrition status.

DIETARY_SUPPLEMENT

Oligosaccharide

oligosaccharide one pack per day

Sponsors & Collaborators

  • Pro-bio Biotech Co. Ltd.

    collaborator INDUSTRY

  • National Cheng-Kung University Hospital

    lead OTHER

Principal Investigators

  • An-Bang WU, MD · National Cheng-Kung University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
16 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2010-03-31
Completion
2011-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01076426 on ClinicalTrials.gov